| Over a week ago | ||||
Healthcare/Food Safety… Healthcare/Food Safety Analyst Vazquez, along with Henry Kamagy, Quality Control Manager at HP Hood, discuss broad trends in the Food Safety Industry and the competitive landscape for legacy Neogen and the acquired 3M food safety businesses on an Analyst/Industry conference call to be held on May 22 at 10 am. | ||||
Healthcare/Food Safety… Healthcare/Food Safety Analyst Vazquez, along with Henry Kamagy, Quality Control Manager at HP Hood, discuss broad trends in the Food Safety Industry and the competitive landscape for legacy Neogen and the acquired 3M food safety businesses on an Analyst/Industry conference call to be held on May 22 at 10 am. | ||||
Healthcare/Food Safety… Healthcare/Food Safety Analyst Vazquez, along with Henry Kamagy, Quality Control Manager at HP Hood, discuss broad trends in the Food Safety Industry and the competitive landscape for legacy Neogen and the acquired 3M food safety businesses on an Analyst/Industry conference call to be held on May 22 at 10 am. | ||||
Neogen has launched two… Neogen has launched two new assays for the detection of natural toxins, Reveal Q+ for DON EndPoint and Reveal Q+ for Aflatoxin EndPoint. Designed to be read on Neogen's Raptor(R) Solo Platform, the EndPoint assays are intended for use in situations where increased workflow output is needed. Both assays have received a Federal Grain Inspection Service (FGIS) Certificate of Compliance for corn and wheat commodities, certifying that the tests meet all of the USDA-FGIS's design and performance standards and can be used for official inspections. | ||||
| Over a month ago | ||||
Piper Sandler analyst… Piper Sandler analyst David Westenberg lowered the firm's price target on Neogen to $19 from $20 and keeps a Neutral rating on the shares. The analyst updated models in the animal health space. | ||||
Reports Q3 revenue… Reports Q3 revenue $218.3M, consensus $218.86M. "The breadth of our product portfolio contributed to both legacy Neogen segments delivering quarterly core growth in a weaker end market environment," said CEO John Adent. "The performance of the former 3M Food Safety Division was mixed, with market demand offset by the production backlog situation at our transition manufacturing partner, where we believe significant engagement from senior levels of their organization and a modified reporting structure provide a path to successful resolution. Despite navigating what we expect to be a transitory issue, market reception to the merger has been positive and we are focused on positioning the combined business for long-term success...We are excited about the opportunities we have ahead of us as the clear, pure-play leader in the food security market, with a portfolio consisting of over 95% consumable products. While our market is not immune to economic slowdowns, it historically has been resilient and has what we believe are long-term, secular tailwinds - heightened pathogen awareness, the growing prevalence of food allergies and increasingly health-conscious consumers who demand to know what's in their food..." | ||||
Neogen announced that the… Neogen announced that the EPA has approved additional virucide claims to its Neogen Viroxide Super disinfectant. These label claims specify that Neogen Viroxide Super kills viruses on hard non-porous surfaces that cause Avian Influenza A, Bovine Viral Diarrhea, Porcine Respiratory and Reproductive Syndrome, and African Swine Fever. In Canada, Health Canada has also approved additional kill claims on non-porous surfaces for viruses that may cause African Swine Fever and Porcine Epidemic Diarrhea. Neogen Viroxide Super is a peroxygen-based powder disinfectant that offers broad-spectrum disinfection when used as part of a comprehensive biosecurity program. | ||||
Here are this week's…
| ||||
| Over a quarter ago | ||||
Piper Sandler analyst… Piper Sandler analyst David Westenberg raised the firm's price target on Neogen to $20 from $17 and keeps a Neutral rating on the shares following the company's earnings report. After having listened to the company's webcast and followed up with management, he thinks "this will be the last reset" of estimates for FY23 and FY24, Westenberg tells investors. | ||||
